Haemonetics (HAE) EBT Growth (3y) (2012 - 2026)
Haemonetics (HAE) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 17.92% |
| 10 | Haemonetics | 4.91 Bn | 4.69 Bn | 202.80 Mn | -2.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -2.67% |
| Mar 28, 2026 | -42.12% |
| Dec 27, 2025 | 12.41% |
| Sep 27, 2025 | 7.69% |
| Jun 28, 2025 | 21.00% |
| Mar 29, 2025 | 66.49% |
| Dec 28, 2024 | 16.72% |
| Sep 28, 2024 | 30.92% |
| Jun 29, 2024 | 159.77% |
| Mar 30, 2024 | 41.86% |
| Dec 30, 2023 | 5.61% |
| Sep 30, 2023 | -15.78% |
| Jul 1, 2023 | 86.29% |
| Apr 1, 2023 | 14.11% |
| Dec 31, 2022 | 3.73% |
| Oct 1, 2022 | -3.07% |
| Jul 2, 2022 | 50.93% |
| Apr 2, 2022 | -11.11% |
| Jan 1, 2022 | 7.22% |
| Oct 2, 2021 | -4.73% |